CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer
June 24 (Reuters) - Cytodyn Inc CYDY.PK:
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.